Management ChangeJun 30, 2026, 05:11 PM
Jupiter Neurosciences Appoints Tomas J. Philipson to Board
AI Summary
Jupiter Neurosciences, Inc. announced the appointment of Dr. Tomas J. Philipson to its Board of Directors, effective June 26, 2026. Dr. Philipson, a distinguished healthcare economist with extensive experience in government and the private sector, will also serve on the Audit and Compensation Committees. In connection with his appointment, he will receive equity compensation, including a sign-on option for 90,000 shares and an option for 446,428 shares in lieu of cash, both vesting over 36 months.
Key Highlights
- Dr. Tomas J. Philipson appointed to the Board of Directors, effective June 26, 2026.
- Dr. Philipson also appointed to the Audit Committee and Compensation Committee.
- He is a healthcare economist with experience in academia, government, and the private sector.
- Served as Acting Chairman of the White House Council of Economic Advisers from 2019-2020.
- Received a sign-on option to purchase 90,000 shares of common stock.
- Received an option to purchase 446,428 shares in lieu of cash compensation.
- Both options vest in equal quarterly installments over 36 months.
Price Impact
More from JUNS